Connor, Clark & Lunn Investment Management (CC&L)’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
|
|||||
|
2025
Q1 | $8.88M | Buy |
|
|||||
|
2024
Q4 | $6.07M | Sell |
|
|||||
|
2024
Q3 | $8.1M | Buy |
|
|||||
|
2024
Q2 | $4.31M | Sell |
|
|||||
|
2024
Q1 | $5.16M | Buy |
|
|||||
|
2023
Q4 | $4.55M | Buy |
|
|||||
|
2023
Q3 | $4.46M | Buy |
|
|||||
|
2023
Q2 | $2.26M | Buy |
|
|||||
|
2023
Q1 | $434K | Buy |
|
|||||
|
2022
Q4 | $335K | Buy |
|